Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Hims & Hers Health, Inc. (HIMS) Reports Q4 Loss of $0.07 on Revenues of $41.7M; Offers 1Q & FY21 Revenues Guidance
March 18, 2021 4:10 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.07), versus ($0.16) reported last year. Revenue for the quarter came in at $41.47 million, versus $41.32 million reported last year.
We closed out this important year for Hims & Hers on a high note, meeting or exceeding the expectations for 2020 performance in our roadshow this past fall, including 80% revenue growth year-over-year and improved gross margins, said Andrew Dudum, CEO and co-founder of Hims & Hers. We also made smart... More



